Alpha-1-antitrypsin deficiency: from genoma to liver disease. PiZ mouse as model for the development of liver pathology in human

Plasminogen activator inhibitor-1 deficient mice are protected from angiotensin II-induced fibrosis

(2011) Juliane I. Beier et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Alpha-1-Antitrypsin Deficiency: Importance of Proteasomal and Autophagic Degradative Pathways in Disposal of Liver Disease–Associated Protein Aggregates

(2010) David H. Perlmutter   Annual Review of Medicine

Characteristics of hepatocellular carcinoma in a murine model of alpha-1-antitrypsin deficiency

(2010) Nancy Y. Marcus et al.   HEPATOLOGY RESEARCH

Proliferative and Nonproliferative Lesions of the Rat and Mouse Hepatobiliary System

(2010) Bob Thoolen et al.   TOXICOLOGIC PATHOLOGY

Differentiation of mouse embryonic stem cells into hepatocytes induced by a combination of cytokines and sodium butyrate

(2009) Mingming Zhou et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Z and Mmalton-1-antitrypsin deficiency-associated hepatocellular carcinoma: a genetic study

(2009) Paola Francalanci et al.   LIVER INTERNATIONAL

Stem and progenitor cells for liver repopulation: can we standardise the process from bench to bedside?

(2008) P Sancho-Bru et al.   GUT